Harpreet S. Dhaliwal - 02 Sep 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Cml Mfg & Supply Chain
Signature
Harpreet S. Dhaliwal, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
02 Sep 2022
Net transactions value
-$39,913
Form type
4
Filing time
07 Sep 2022, 16:36:23 UTC
Previous filing
04 Mar 2022
Next filing
30 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability $39,913 -1,513 -8.2% $26.38 16,890 02 Sep 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
F2 Includes 903 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 17, 2022.